BEGIN:VCALENDAR
VERSION:2.0
PRODID:icalendar-ruby
CALSCALE:GREGORIAN
X-WR-CALNAME:Colloquia on Cannabis Research: Kent Hutchison
X-WR-TIMEZONE:Mountain Time (US & Canada)
BEGIN:VEVENT
DTSTAMP:20260609T204907Z
UID:tag:localist.com\,2008:EventInstance_3955141
DTSTART:20180921T193000Z
DTEND:20180921T203000Z
DESCRIPTION:Abstract:\n\nCannabis has been legalized in one form or another
  in the majority of the U.S.\, Canada\, Mexico and various other countries
  around the world. There is a clear need for updated and timely empirical 
 evidence regarding the potential health benefits and risks of cannabis to 
 guide policy making and consumer decisions regarding cannabis use\, especi
 ally given the number of people who are turning to cannabis as an answer t
 o opiate addiction and chronic pain. Considering the significant public he
 alth implications of increasing access to marijuana\, research on the heal
 th effects of marijuana should be a high priority for congressional repres
 entatives from every state in the U.S.\n\nTo understand the health effects
  of medical marijuana\, the potential risks need to be weighed again the p
 otential benefits. In that context\, the first part of the presentation wi
 ll summarize data on the potential risks of medical marijuana. Studies cle
 arly suggest that THC may have short term deleterious effects on cognition
 \, although these effects may be mitigated by other cannabinoids like CBD.
  However\, these effects may be less pronounced in regular users and medic
 al patients. The evidence for long­term negative effects of medical marij
 uana on brain structure and cognition is not particularly strong\, particu
 larly in medical populations. With respect to potential benefits\, recent 
 evidence suggests that many individuals are using medical marijuana to sel
 f­treat chronic pain and reduce opiate use. In addition\, recent systemat
 ic reviews of randomized clinical trials indicate that cannabis has some e
 fficacy in the treatment of pain\, particularly neuropathic pain. Specific
  cannabinoids have also demonstrated efficacy for other diseases states (e
 .g.\, CBD for seizures). In short\, while there is no evidence to suggest 
 that marijuana represents a “panacea\,” it does seem clear that for ma
 ny patients\, the benefits of specific marijuana products clearly outweigh
  the risks. What is also abundantly clear is that public acceptance of med
 ical marijuana in the U.S. has greatly outpaced the existing research. For
  the cancer patient who asks their oncologist for information about the me
 dical effect of marijuana or the policy maker who would like to make polic
 y based on scientific evidence\, this is clearly a situation that needs to
  be addressed.\n\nBio:\n\nKent Hutchison\, PhD\, is a professor of psychol
 ogy and neuroscience at the University of Colorado in Boulder. Dr. Hutchis
 on has been an NIH funded scientist for the past 20 years and has publishe
 d numerous papers in the area of substance use. Dr. Hutchison recently ser
 ved on the National Academy of Sciences committee that reviewed the effect
  of cannabis on health and released a report in the fall of 2016. Dr. Hutc
 hison is the principal investigator (or co­investigator) on three new NIH
  funded studies that examine the effects of cannabis products (e.g.\, flow
 er\, edibles\, concentrates) purchased in the state of Colorado. Specifica
 lly\, the studies are designed to compared the effects of CBD only\, THC+C
 BD\, or THC only on anxiety\, pain\, and cognition\, in patient population
 s using a mobile pharmacology lab. The mobile lab allows for the collectio
 n of blood levels of THC and CBD and a test of whether blood levels of the
 se cannabinoids predict the effects of cannabis on key outcomes (e.g.\, re
 ductions in pain and opiate use). Importantly\, this approach is also cons
 istent with federal laws that have restricted cannabis research in the pas
 t. Most recently\, Dr. Hutchison founded research center focused on the he
 alth effects of cannabis. The overarching objective of center is to facili
 tate research that will better inform policy makers\, as well as patients\
 , about the potential benefits and risks of cannabis products available in
  states that have legalized access.\n\nBackground:\n\nIn connection with t
 he new University of Colorado Research and Education Addressing Cannabinoi
 ds and Health (CU REACH)\, the Colloquium on Cannabis Research is a monthl
 y research seminar focused on the science\, technology\, business\, and hi
 story of cannabis. Each session will feature a speaker giving a 45 minute 
 presentation followed by 15 minutes of discussion. This is a non­consumpt
 ion event dedicated to discussing academic research about cannabis.
LOCATION:Center for Academic Success and Engagement (CASE)\, E351
SUMMARY:Colloquia on Cannabis Research: Kent Hutchison
URL;VALUE=URI:https://calendar.colorado.edu/event/colloquia_on_cannabis_res
 earch_kent_hutchison
CATEGORIES:Colloquium/Seminar
END:VEVENT
END:VCALENDAR